← Back to Search

Light Therapy

Blue light phototherapy for Grover's Disease

N/A
Waitlist Available
Led By Shuai Xu
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame: 1 year
Awards & highlights

Study Summary

This trial will see if blue-light therapy can improve symptoms in patients with psoriasis or Grover's Disease.

Eligible Conditions
  • Grover's Disease
  • Plaque Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assess User Experience With the Dermatology Life Quality Index (DLQI) Pre and Post-treatment.
Efficacy of Blue Light Therapy for Patients With Grover's Disease
Secondary outcome measures
Cellular analysis of Blue light phototherapy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Adult treatment armExperimental Treatment1 Intervention
Adults enrolled in the study will receive treatment (blue light phototherapy) on one area of their body affected by psoriasis or Grover's disease. The treatment area (restricted by size of the device) will be compared to untreated areas affected by disease on the same patient.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blue light phototherapy
2020
N/A
~20

Find a Location

Who is running the clinical trial?

T-Cellerate LLCUNKNOWN
Northwestern UniversityLead Sponsor
1,592 Previous Clinical Trials
918,031 Total Patients Enrolled
Shuai XuPrincipal InvestigatorNorthwestern University
6 Previous Clinical Trials
296 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are being enrolled in this investigation?

"Affirmative. Clinicaltrials.gov hosts data verifying that this investigation is currently enlisting participants, which was initially posted on September 1st 2020. Just 20 individuals need to be recruiting from one location for the trial to commence."

Answered by AI

Who meets the criteria for participation in this clinical experiment?

"This clinical trial is aiming to recruit 20 adults aged 18-89 who have been medically diagnosed with psoriasis vulgaris or Grover's disease."

Answered by AI

Does this experiment enlist participants who are more than 30 years old?

"To be eligible for this particular trial, individuals must be aged between 18 and 89. There are 31 additional trials available to those under the age of consent, as well as 143 studies tailored for patients above 65 years old."

Answered by AI

Is this research endeavor in need of additional participants?

"Affirmative. According to clinicaltrials.gov, this particular medical trial is actively recruiting participants since it was published on September 1st 2020 and updated for the last time on June 8th 2022. 20 potential patients must be sourced from a solitary site."

Answered by AI
~2 spots leftby May 2025